Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis
NCT00546663
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
19
Enrollment
NETWORK
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
inhaled 7% hypertonic saline (HS)
Sponsor
CF Therapeutics Development Network Coordinating Center
Collaborators
[object Object]